Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06922526

Pacemaker-related Tricuspid Regurgitation Progression and Long-term Outcomes

Predictors of Tricuspid Regurgitation Progression and Adverse Outcomes in Different Pacing Modes

Status
Recruiting
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Haiyan Wang · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Tricuspid regurgitation (TR) is a common complication following cardiac implantable electronic device (CIED) implantation, with severe TR being associated with increased rates of heart failure hospitalization and all-cause mortality, significantly impairing patients' quality of life. With technological advancements, physiological pacing modalities have demonstrated superior clinical efficacy and safety profiles compared to conventional pacing methods. This study aims to evaluate predictors of adverse outcomes and TR progression in CIED recipients under different pacing modalities, thereby providing clinical guidance for high-risk patients.

Detailed description

This retrospective study analyzed patients undergoing pacemaker implantation from January 2015 to March 2025, stratified by pacing modality (right ventricular/conduction system/biventricular pacing) and TR progression (worsened \[≥1-grade increase\] vs non-worsened TR). The protocol included: (1) 3D echocardiographic assessment of TR mechanisms, (2) quantitative fluoroscopic analysis of lead parameters (tension, mobility, angulation), (3) multivariable regression evaluating pacing modes and TR progression on clinical outcomes, and (4) documentation of device-related complications (lead dislodgement/infection) and heart failure rehospitalization.

Conditions

Interventions

TypeNameDescription
DEVICEPacemaker implantationPacemaker implantation methods include right ventricular pacing, biventricular pacing, conduction system pacing

Timeline

Start date
2025-04-01
Primary completion
2026-03-01
Completion
2026-05-01
First posted
2025-04-10
Last updated
2025-04-30

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06922526. Inclusion in this directory is not an endorsement.